Quest PharmaTech: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (QPT)
Quest PharmaTech is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| KOVO | Kovo Healthtech | 0.04 | 0.14 | 0.09 (207.4%) | 23431 | 2.6 | 0.0 | 0.0 |
| PSYB | PsyBio Therapeutics | 0.01 | 0.03 | 0.02 (190.4%) | 1.3 | 0.0 | 0.0 | |
| LFST | Lifeist Wellness | 0.01 | 0.03 | 0.02 (163.1%) | 717480 | 4.7 | 0.0 | 0.0 |
| BTI | Bioasis Technologies | 0.01 | 0.01 | 0.01 (160.3%) | 72282 | 0.4 | 0.0 | 0.0 |
| VIV | Avivagen | 0.01 | 0.01 | 0.01 (155.8%) | 46328 | 0.4 | 0.0 | 0.0 |
| NPTH | NeuPath Health | 0.18 | 0.38 | 0.20 (113.7%) | 9694 | 10.2 | 0.0 | 0.0 |
| QPT | Quest PharmaTech | 0.03 | 0.05 | 0.02 (94.0%) | 45848 | 4.2 | 0.0 | 0.0 |
| JNH | Jack Nathan Medical | 0.06 | 0.11 | 0.05 (75.2%) | 37479 | 5.4 | 0.0 | 0.0 |
| HEM | Hemostemix | 0.08 | 0.14 | 0.06 (72.3%) | 37090 | 6.8 | 0.0 | 0.0 |
| HMPG | Hempshire Gr | 0.01 | 0.01 | 0.00 (66.1%) | 31194 | 0.4 | 0.0 | 0.0 |
All data provided as of February 16, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Quest PharmaTech
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Quest PharmaTech is listed under QPT on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
